Cormorant Asset Management’s Zentalis Pharmaceuticals ZNTL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-700,000	Closed	-$14M	–	56
2023 Q3	$14M	Sell	700,000 -395,000	-36%	-$7.92M	0.82%	30
2023 Q2	$30.9M	Buy	+1,095,000	New	+$30.9M	1.73%	13